1. Home
  2. EMBC vs OPY Comparison

EMBC vs OPY Comparison

Compare EMBC & OPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMBC
  • OPY
  • Stock Information
  • Founded
  • EMBC 1924
  • OPY 1881
  • Country
  • EMBC United States
  • OPY United States
  • Employees
  • EMBC N/A
  • OPY N/A
  • Industry
  • EMBC Medical/Dental Instruments
  • OPY Investment Bankers/Brokers/Service
  • Sector
  • EMBC Health Care
  • OPY Finance
  • Exchange
  • EMBC Nasdaq
  • OPY Nasdaq
  • Market Cap
  • EMBC 726.8M
  • OPY 766.7M
  • IPO Year
  • EMBC N/A
  • OPY N/A
  • Fundamental
  • Price
  • EMBC $9.96
  • OPY $73.31
  • Analyst Decision
  • EMBC Buy
  • OPY
  • Analyst Count
  • EMBC 2
  • OPY 0
  • Target Price
  • EMBC $19.00
  • OPY N/A
  • AVG Volume (30 Days)
  • EMBC 526.4K
  • OPY 54.7K
  • Earning Date
  • EMBC 08-08-2025
  • OPY 08-01-2025
  • Dividend Yield
  • EMBC 5.91%
  • OPY 0.99%
  • EPS Growth
  • EMBC N/A
  • OPY 41.03
  • EPS
  • EMBC 0.89
  • OPY 7.71
  • Revenue
  • EMBC $1,079,500,000.00
  • OPY $1,400,394,000.00
  • Revenue This Year
  • EMBC N/A
  • OPY N/A
  • Revenue Next Year
  • EMBC N/A
  • OPY N/A
  • P/E Ratio
  • EMBC $11.39
  • OPY $9.84
  • Revenue Growth
  • EMBC N/A
  • OPY 14.40
  • 52 Week Low
  • EMBC $9.20
  • OPY $47.39
  • 52 Week High
  • EMBC $21.48
  • OPY $77.83
  • Technical
  • Relative Strength Index (RSI)
  • EMBC 43.81
  • OPY 63.51
  • Support Level
  • EMBC $9.68
  • OPY $72.00
  • Resistance Level
  • EMBC $11.79
  • OPY $77.83
  • Average True Range (ATR)
  • EMBC 0.51
  • OPY 1.84
  • MACD
  • EMBC -0.05
  • OPY 0.25
  • Stochastic Oscillator
  • EMBC 22.12
  • OPY 62.36

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About OPY Oppenheimer Holdings Inc. (DE)

Oppenheimer Holdings Inc conducts activities in the securities industry. The company is involved in retail securities brokerage, investment banking (both corporate and public finance), institutional sales and trading, market-making, research, trust services, and investment advisory and asset management services. The company has two segments: Wealth Management, and Capital Markets. IT generates maximum revenue from Wealth Management Segment which includes commissions and fee income earned on assets under management (AUM), net interest earnings on client margin loans and cash balances, fees from money market funds, custodian fees and other activities. The company generates the majority of its revenue from the Americas, with the rest from Europe, the Middle East, and Asia.

Share on Social Networks: